Bioinformatics Institute of India (BII) actively participated in 60th Indian Pharmaceutical Congress 2008 held at Netaji Subhas Institute of Technology, New Delhi from December 12 – 14, 2008. The event was one of the largest events of pharmaceutical industry in India where more than 250 exhibitors took this opportunity to display their products & services. The event was attended by more...
Bioinformatics Institute of India (BII) actively participated in 60th Indian Pharmaceutical Congress 2008 held at Netaji Subhas Institute of Technology, New Delhi from December 12 – 14, 2008. The event was one of the largest events of pharmaceutical industry in India where more than 250 exhibitors took this opportunity to display their products & services. The event was attended by more...
Admissions are open in BII for various distance learning & classroom programs in the area of Bioinformatics, Pharma, Clinical trial, Biotechnology etc.
Bioinformatics Institute of India announces Admission notice for its next batch of weekend “Advance Program in Clinical Trial, Research and Data managementâ€. This weekend program is of 6 months duration and will commence from 15th December’08 at BII Noida. The ongoing batch of the program is quite successful and is pursued by many doctors, medical professionals, B.Pharma, B.Sc & other...
Established in 2002 Bioinformatics Institute of India (BII) is a reputed and pioneering institution for imparting quality education and training in the different emerging disciplines of Life Sciences. BII is today recognized across the globe as a premier institution offering programs in the area of Bioinformatics, Clinical Trials, Pharma Regulatory affairs, Pharma Quality Assurance and Control...
Bioinformatics Institute of India is happy to announce that we have recently prepared a Clinical Trial Directory covering: · Leading Companies in Clinical Trials and Research. · Leading Job Consultants in Clinical Trials · Job prospects & various roles in Clinical Trials Industry. This directory has been prepared due to significant demand from clinical trial companies and individuals. We...